WO2001070814A3 - Regulation du recepteur de la proteine g semblable a la rta humaine - Google Patents

Regulation du recepteur de la proteine g semblable a la rta humaine Download PDF

Info

Publication number
WO2001070814A3
WO2001070814A3 PCT/EP2001/003336 EP0103336W WO0170814A3 WO 2001070814 A3 WO2001070814 A3 WO 2001070814A3 EP 0103336 W EP0103336 W EP 0103336W WO 0170814 A3 WO0170814 A3 WO 0170814A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
coupled receptor
asthma
regulation
infections
Prior art date
Application number
PCT/EP2001/003336
Other languages
English (en)
Other versions
WO2001070814A2 (fr
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Ag
Shyam Ramakrishnan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Shyam Ramakrishnan filed Critical Bayer Ag
Priority to EP01933743A priority Critical patent/EP1268548A2/fr
Priority to AU2001260147A priority patent/AU2001260147A1/en
Publication of WO2001070814A2 publication Critical patent/WO2001070814A2/fr
Publication of WO2001070814A3 publication Critical patent/WO2001070814A3/fr
Priority to US11/332,138 priority patent/US20060121554A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des réactifs qui régulent le récepteur couplé à la protéine G semblable à la RTA humaine pouvant servir en cas d'infections bactériennes, fongiques, protozoaires ou virales et en particulier celles causées par le virus HIV, les douleurs, les cancers, l'anorexie, la boulimie, l'asthme, la maladie de Parkinson, les attaques cardiaques aiguës, l'hypotension, l'hypertension, la rétention d'urine, l'ostéoporose, l'angine de poitrine, l'infarctus du myocarde, les ulcères, les allergies, la sclérose en plaques, l'hypertrophie prostatique bénine et les troubles neurologiques et psychotiques, y compris ceux causés par l'angoisse, la schizophrénie, la psychose maniaco-dépressive, le délire, la démence, plusieurs types de retards mentaux et des dyskinésies, telles que la maladie d'Huntington ou le syndrome de Tourett.
PCT/EP2001/003336 2000-03-24 2001-03-23 Regulation du recepteur de la proteine g semblable a la rta humaine WO2001070814A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01933743A EP1268548A2 (fr) 2000-03-24 2001-03-23 Regulation du recepteur de la proteine g semblable a la rta humaine
AU2001260147A AU2001260147A1 (en) 2000-03-24 2001-03-23 Regulation of human rta-like g protein-coupled receptor
US11/332,138 US20060121554A1 (en) 2000-03-24 2006-01-17 Regulation of human RTA-like GPCR

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19176500P 2000-03-24 2000-03-24
US60/191,765 2000-03-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/332,138 Continuation US20060121554A1 (en) 2000-03-24 2006-01-17 Regulation of human RTA-like GPCR

Publications (2)

Publication Number Publication Date
WO2001070814A2 WO2001070814A2 (fr) 2001-09-27
WO2001070814A3 true WO2001070814A3 (fr) 2002-04-11

Family

ID=22706848

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003336 WO2001070814A2 (fr) 2000-03-24 2001-03-23 Regulation du recepteur de la proteine g semblable a la rta humaine

Country Status (3)

Country Link
EP (1) EP1268548A2 (fr)
AU (1) AU2001260147A1 (fr)
WO (1) WO2001070814A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064822A1 (en) * 2000-03-13 2002-05-30 Ming-Hui Wei Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
US7510845B2 (en) 2000-05-04 2009-03-31 California Institute Of Technology Assay employing G protein-coupled receptor expressed in dorsal root ganglia
US20030092035A1 (en) 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
WO2002000699A1 (fr) * 2000-06-26 2002-01-03 Bayer Aktiengesellschaft Regulation du recepteur humain couple a la proteine g semblable a la rta
EP1474176A4 (fr) * 2001-11-26 2005-06-15 Bristol Myers Squibb Co Nouveau recepteur couple a la proteine g humaine, hgprbmy31, variants et procedes d'utilisation de ce dernier
AU2003227268A1 (en) * 2002-03-28 2003-10-13 Takeda Chemical Industries, Ltd. Novel screening method
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000023676A (ja) * 1998-07-14 2000-01-25 Asahi Chem Ind Co Ltd ７回膜貫通型受容体蛋白質ｅｒｇ５
WO2000020580A1 (fr) * 1998-10-08 2000-04-13 Takeda Chemical Industries, Ltd. Nouvelle proteine recepteur couplee a la proteine g et adn associe
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527107A (ja) * 2000-02-02 2003-09-16 インサイト・ゲノミックス・インコーポレイテッド Ｇタンパク質結合受容体
US20040014169A1 (en) * 2000-03-08 2004-01-22 Gabriel Vogeli Novel G protein-coupled receptors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000023676A (ja) * 1998-07-14 2000-01-25 Asahi Chem Ind Co Ltd ７回膜貫通型受容体蛋白質ｅｒｇ５
WO2000020580A1 (fr) * 1998-10-08 2000-04-13 Takeda Chemical Industries, Ltd. Nouvelle proteine recepteur couplee a la proteine g et adn associe
EP1122313A1 (fr) * 1998-10-08 2001-08-08 Takeda Chemical Industries, Ltd. Nouvelle proteine recepteur couplee a la proteine g et adn associe
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 3 December 1999 (1999-12-03), HATTORI M. ET AL.: "Homo sapiens genomic DNA, chromosome 11q13, clone:RP11-757G1, WORKING DRAFT SEQUENCE, 24 unordered pieces", XP002184754 *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 04 31 August 2000 (2000-08-31) *
See also references of EP1268548A2 *

Also Published As

Publication number Publication date
WO2001070814A2 (fr) 2001-09-27
EP1268548A2 (fr) 2003-01-02
AU2001260147A1 (en) 2001-10-03

Similar Documents

Publication Publication Date Title
EP0867508A3 (fr) Olfactif recepteur du famille du 7-transmembranes recepteurs - OLRCC15 recepteur
EP1154019A3 (fr) Récepteur couplé à une protéine G (HFGAN72X)
EP0893498A3 (fr) Clone de cADN MY1 codant pour un récepteur 7-transmembranaire humain
EP0834563A3 (fr) Récepteur transmembranaire humain, membre de la famille des récepteurs de chémokines, appelé aussi Strl-33
EP1156110A3 (fr) Récepteur couplé à une protéine G (HFGAN72Y)
EP0892051A3 (fr) Clone heoad54 de CADN codant pour un récepteur 7-transmembranaire humaine
EP0899332A3 (fr) HFIAO41, un récepteur couplé à la protéine G
EP0853126A3 (fr) Clone HE8C54q de cADN codant pour un récepteur 7-transmembranaire humain
EP0885960A3 (fr) Récepteur couplé à la protéine g (H7TBA62)
EP0913471A3 (fr) Clone HNEAA81 de CADN codant pour un récepteur 7-transmembranaire humain
WO2001070814A3 (fr) Regulation du recepteur de la proteine g semblable a la rta humaine
WO2001077320A3 (fr) Regulation du recepteur couple aux proteines g humain du type hm74
WO2001094385A8 (fr) Regulation du recepteur couple a la proteine humaine g de type hm74
EP1311677B8 (fr) Regulation du recepteur couple a la proteine g humaine du type p2y1
EP0881289A3 (fr) Recepteur 7TM (H2CAA71)
WO2001004139A3 (fr) Sequences polynucleotidiques et polypeptidiques du recepteur humain axor29 et procedes de detection d'agonistes et d'antagonistes de l'interaction entre ce recepteur humain axor29 et ses ligands
AU7051901A (en) Regulation of human alpha1a adrenergic receptor-like g protein-coupled receptor
EP0878542A3 (fr) Clone HMTMF81 de cADN codant pour un nouveau récepteur 7-transmembranaire humain
EP0853125A3 (fr) Clone HNFJD15 de cADN codant pour un récepteur 7-transmembranaire humain
WO2001068842A3 (fr) Regulation de la proteine humaine gpcr similaire a p2y
WO2001068702A3 (fr) Regulation du recepteur couple a une proteine g humaine
WO2001070971A3 (fr) Regulation du recepteur couple a la proteine g associee a l'oncogene mas humain
EP0894854A3 (fr) Nouveau variant d'épissage du récepteur couplé à la protéine G induit par le virus d'Epstein-Barr
EP0878479A3 (fr) Récepteur couplé à la protéine G (HOFNH30)
WO2001068701A3 (fr) Regulation du recepteur humain couple a la proteine g de type transmembranaire a sept domaines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001933743

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001933743

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10239421

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP